Fecal microbiota transplantation treatment for refractory ulcerative colitis with allergy to 5-aminosalicylic acid

AbstractIntroduction:Fecal microbiota transplantation (FMT) is currently being explored as a potential therapy for ulcerative colitis (UC). Here, we report the first case of a UC patient with allergy to 5-aminosalicylic acid (5-ASA) who underwent FMT and achieved clinical remission.Case presentation